CTI BioPharma (CTIC) Announces $10M Milestone Payment from Teva Pharmaceuticals (TEVA) for TRISENOX
Tweet Send to a Friend
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that it expects to receive a $10 million milestone payment in February, 2018 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
